A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: A possible role to suppress cell proliferation

International Journal of Experimental Pathology

Volumn 89, Issue 5, 2008, Pages 332-341

  Yamamoto, Tomoko ^a   Kato, Yoichiro ^a   Shibata, Noriyuki ^a   Sawada, Tatsuo ^a   Osawa, Makiko ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

dystroglycan; c jun; Cancer; Cell proliferation; Fukutin; RNA interference

Indexed keywords

ALPHA DYSTROGLYCAN; FUKUTIN; KI 67 ANTIGEN; LAMININ; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BASEMENT MEMBRANE; BINDING ASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME PHOSPHORYLATION; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE FUNCTION; GOLGI COMPLEX; HELA CELL; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; RNA INTERFERENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; DYSTROGLYCANS; GLYCOSYLATION; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, IMMUNOELECTRON; MUSCULAR DYSTROPHIES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 51349085514     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00599.x     Document Type: Article

References (37)

1. Akasaka-Manya K., Manya H., Endo T. (2004) Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation. Biochem. Biophys. Res. Commun. 325, 75 79.
2. Beltrán-Valero de Bernabé D., Currier S., Steinbrecher A. et al. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71, 1033 1043.
3. Cattoretti G., Becker M.H.G., Key G. et al. (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 168, 357 363.
4. Chiyonobu T., Sasaki J., Nagai Y. et al. (2005) Effects of fukutin deficiency in the developing brain. Neuromuscul. Disord. 15, 416 426.
5. El-Tanani M.K., Campbell F.C., Kurisetty V., Jin D., McCann M., Rudland P.S. (2006) The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17, 463 474.
6. Ervasti J.M. Campbell K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809 823.
7. Gerdes J., Lemke H., Baisch H., Wacker H.-H., Schwab U., Stein H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710 1715.
8. Hayashi Y.K., Ogawa M., Tagawa K. et al. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57, 115 121.
9. Jing J., Lien C.F., Sharma S., Rice J., Brennan P.A., Górecki D.C. (2004) Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur. J. Cancer 40, 2143 2151.
10. Kim D.-S., Hayashi Y.K., Matsumoto H. et al. (2004) POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in α-DG. Neurology 62, 1009 1011.
11. Kobayashi K., Nakahori Y., Miyake M. et al. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388 392.
12. Kurahashi H., Taniguchi M., Meno C. et al. (2005) Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol. Dis. 19, 208 217.
13. Manya H., Sakai K., Kobayashi K. et al. (2003) Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 306, 93 97.
14. Martin P.T. (2005) The dystroglycanopathies: the new disorders of O-linked glycosylation. Semin. Pediatr. Neurol. 152, 152 158.
15. Matsumoto H., Noguchi S., Sugie K. et al. (2004) Subcellular localization of fukutin and fukutin-related protein in muscle cells. J. Biochem. 135, 709 712.
16. Michele D.E. Campbell K.P. (2003) Dystrophin-glycoprotein complex: post-transcriptional processing and dystroglycan function. J. Biol. Chem. 278, 15457 15460.
17. Michele D.E., Barresi R., Kanagawa M. et al. (2002) Post-transcriptional disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417 421.
18. Morgan D., Murray A., Hunt T., Nurse P. (2002) The cell cycle and programmed cell death. In : Molecular Biology of the Cell. 4th edn, pp. 983 1026 (eds B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter New York : Garland Science.
19. Muschler J., Levy D., Boudreau R., Henry M., Campbell K., Bissell M.J. (2002) A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res. 62, 7102 7109.
20. Nateri A.S., Spencer-Dene B., Behrens A. (2005) Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437, 281 285.
21. Oak S.A., Zhou Y.W., Jarrett H.W. (2003) Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1. J. Biol. Chem. 278, 39287 39295.
22. Russo K., Di Stasio E., Macchia G., Rosa G., Brancaccio A., Petrucci T.C. (2000) Characterization of the β-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem. Biophys. Res. Commun. 274, 93 98.
23. Saito Y., Mizuguchi M., Oka A., Takashima S. (2000) Fukutin protein is expressed in neurons of the normal developing human brain but is reduced in fukuyama-type congenital muscular dystrophy brain. Ann. Neurol. 47, 756 764.
24. Saito Y., Yamamoto T., Ohtsuka-Tsurumi E. et al. (2004) Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Brain Dev. 26, 469 479.
25. Schessl J., Zou Y., Bönnemann C.G. (2006) Congenital muscular dystrophies and the extracellular matrix. Semin. Pediatr. Neurol. 13, 80 89.
26. Sgambato A. Brancaccio A. (2005) The dystroglycan complex: from biology to cancer. J. Cell. Physiol. 205, 163 169.
27. Sgambato A., Migaldi M., Montanari M. et al. (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 162, 849 860.
28. Sgambato A., Tarquini E., Resci F. et al. (2006) Aberrant expression of α-dystroglycan in cervical and vulvar cancer. Gynecol. Oncol. 103, 397 404.
29. Sotgia F., Lee H., Bedford M.T., Petrucci T., Sudol M., Lisanti M.P. (2001) Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40, 14585 14592.
30. Takahashi S., Sasaki T., Manya H. et al. (2001) A new β1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 11, 37 45.
31. Vleugel M.M., Greijer A.E., Bos R., van der Wall E., van Diest P.J. (2006) c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37, 668 674.
32. Yamamoto T., Kato Y., Karita M. et al. (2002) Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy. Acta Neuropathol. 104, 217 224.
33. Yamamoto T., Kato Y., Karita M., Kawaguchi M., Shibata N., Kobayashi M. (2004a) Expression of genes related to muscular dystrophy with lissencephaly. Pediatr. Neurol. 31, 183 190.
34. Yamamoto T., Kato Y., Kawaguchi M., Shibata N., Kobayashi M. (2004b) Expression and localization of fukutin, POMGnT1 and POMT1 in the central nervous system: consideration for functions of fukutin. Med. Electron Microsc. 37, 200 207.
35. Yoshida A., Kobayashi K., Manya H. et al. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1, 717 724.
36. Zhang G., Luo X., Sumithran E. et al. (2006) Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 25, 7260 7266.
37. Zhou Y.W., Jiang D., Thomason D.B., Jarrett H.W. (2007) Laminin-induced activation of Rac1 and JNKp46 is initiated by src family kinases and mimics the effects of skeletal muscle contraction. Biochemistry 46, 14907 14916.